Erratum: A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116)

Thomas F. Rocereto; William E. Brady; Mark S. Shahin; James S. Hoffman; Laurie Small; Jacob Rotmensch; Robert S. Mannel

doi:10.1016/j.ygyno.2010.04.019

Erratum: A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116)

Thomas F. Rocereto
, William E. Brady
, Mark S. Shahin
, James S. Hoffman
, Laurie Small
, Jacob Rotmensch
, Robert S. Mannel

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	208
Number of pages	1
Journal	Gynecologic Oncology
Volume	118
Issue number	2
DOIs	https://doi.org/10.1016/j.ygyno.2010.04.019
State	Published - Aug 1 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2010.04.019

Cite this

Rocereto, T. F., Brady, W. E., Shahin, M. S., Hoffman, J. S., Small, L., Rotmensch, J., & Mannel, R. S. (2010). Erratum: A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116). Gynecologic Oncology, 118(2), 208. https://doi.org/10.1016/j.ygyno.2010.04.019

@article{a2023312400d4b55bf16812ded884b2a,

title = "Erratum: A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116)",

author = "Rocereto, \{Thomas F.\} and Brady, \{William E.\} and Shahin, \{Mark S.\} and Hoffman, \{James S.\} and Laurie Small and Jacob Rotmensch and Mannel, \{Robert S.\}",

year = "2010",

month = aug,

day = "1",

doi = "10.1016/j.ygyno.2010.04.019",

language = "English (US)",

volume = "118",

pages = "208",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "2",

}

Rocereto, TF, Brady, WE, Shahin, MS, Hoffman, JS, Small, L, Rotmensch, J & Mannel, RS 2010, 'Erratum: A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116)', Gynecologic Oncology, vol. 118, no. 2, pp. 208. https://doi.org/10.1016/j.ygyno.2010.04.019

Erratum: A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116). / Rocereto, Thomas F.; Brady, William E.; Shahin, Mark S. et al.
In: Gynecologic Oncology, Vol. 118, No. 2, 01.08.2010, p. 208.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116)

AU - Rocereto, Thomas F.

AU - Brady, William E.

AU - Shahin, Mark S.

AU - Hoffman, James S.

AU - Small, Laurie

AU - Rotmensch, Jacob

AU - Mannel, Robert S.

PY - 2010/8/1

Y1 - 2010/8/1

UR - https://www.scopus.com/pages/publications/77954244598

UR - https://www.scopus.com/pages/publications/77954244598#tab=citedBy

U2 - 10.1016/j.ygyno.2010.04.019

DO - 10.1016/j.ygyno.2010.04.019

M3 - Comment/debate

AN - SCOPUS:77954244598

SN - 0090-8258

VL - 118

SP - 208

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 2

ER -

Rocereto TF, Brady WE, Shahin MS, Hoffman JS, Small L, Rotmensch J et al. Erratum: A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116). Gynecologic Oncology. 2010 Aug 1;118(2):208. doi: 10.1016/j.ygyno.2010.04.019

Erratum: A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study (Gynecologic Oncology (2010) 116)

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this